Table 1.
Patient characteristics.
| PatientNo. | Age(y) | Gleason score | Days from PSMA PET/CT To FDG PET/CT | initial PSA (ng/mL) | Local tumor growth (n) | Lymph node metastases (n) | bone metastases (n) | |||
|---|---|---|---|---|---|---|---|---|---|---|
| FDG | PSMA | FDG | PSMA | FDG | PSMA | |||||
| 1 | 73 | 4 | 183.00 | 1 | 1 | >10 | >10 | >10 | >10 | |
| 2 | 63 | 4+3 | 9 | 5.00 | 1 | 1 | 0 | 1 | 0 | 3 |
| 3 | 71 | 4+5 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | |
| 4 | 74 | 3+4 | 4 | 10.65 | 0 | 1 | 0 | 1 | 0 | 0 |
| 5 | 72 | 4+4 | 7 | 30.14 | 1 | 1 | 1 | 5 | 0 | 2 |
| 6 | 82 | 3 | 100.00 | 1 | 1 | 2 | 3 | >10 | >10 | |
| 7 | 64 | 5+4 | 3 | 153.00 | 0 | 2 | >10 | >10 | >10 | >10 |
| 8 | 80 | 1 | 70.50 | 0 | >2 | 1 | 5 | 2 | 6 | |
| 9 | 63 | 4+3 | 5 | 147.00 | 1 | 1 | 0 | 5 | 1 | 1 |
| 10 | 68 | 5+5 | 34 | 16.22 | 1 | 2 | 0 | 0 | 0 | 1 |
| 11 | 68 | 4+3 | 9.90 | 1 | >2 | 0 | 7 | 0 | 3 | |
| 12 | 74 | 4+4 | 18 | 25.63 | 1 | >2 | 0 | 0 | 0 | 1 |
| 13 | 50 | 7 | 15.50 | 1 | 1 | 0 | 3 | 1 | 2 | |
| 14 | 65 | 4+5 | 9 | 0 | 1 | 0 | 4 | 0 | 0 | |
| 15 | 66 | 4+4 | 6 | 184.00 | 1 | 1 | 1 | 5 | 0 | 0 |
| 16 | 66 | 5+4 | 5 | 50.80 | 0 | 1 | 4 | 7 | 0 | 0 |
| 17 | 56 | 3+4 | 9 | 31.60 | 0 | 1 | 0 | 2 | 2 | 4 |
| 18 | 65 | 4+5 | 7 | 91.30 | 1 | 2 | 5 | 6 | >10 | >10 |
| 19 | 75 | 7 | 1 | 1 | 0 | 0 | 0 | 2 | ||
| 20 | 56 | 5+5 | 11 | 200.00 | 1 | >2 | 0 | 2 | 0 | 0 |
| 21 | 64 | 4+4 | 3 | 20.01 | 0 | 1 | 0 | 0 | 6 | 6 |